MetaADEDB 2.0 @ LMMD
Estrogens, Conjugated (USP)
(VUCAHVBMSFIGAI-ZFINNJDLSA-M)
Structure
SMILES
O=C1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCc2c1ccc(c2)OS(=O)(=O)[O-].[Na+]
Molecular Formula:
C18H21NaO5S
Molecular Weight:
372.411
Log P:
4.0316
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
0
TPSA:
91.88
CAS Number(s):
438-67-5
Synonym(s)
1.
Estrogens, Conjugated (USP)
2.
Estrogenic Substances, Conjugated
3.
Carentil
4.
Climarest
5.
Climopax
6.
Congest
7.
Conjugated Equine Estrogens
8.
Conjugated Estrogens
9.
Dagynil
10.
Estro-Feminal
11.
Estrogenic Hormones, Conjugated
12.
Estrogens, Conjugated
13.
Femavit
14.
Oestro-Feminal
15.
Oestrofeminal
16.
Prelestrin
17.
Premarin
18.
Presomen
19.
Progens
20.
Transannon
21.
Conjugated Estrogenic Hormones
22.
Conjugated Estrogenic Substances
23.
Equine Estrogens, Conjugated
24.
Estro Feminal
25.
Oestro Feminal
External Link(s)
MeSHD004966
PubChem Compound23667301
ChEBI8389
CHEMBLCHEMBL2106240
KEGGdr:D00312
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 817
Canada Vigilance: 40
Canada Vigilance
US FAERS
2Vulvovaginal burning sensationFAERS: 244
Canada Vigilance: 3
Canada Vigilance
US FAERS
3MalaiseFAERS: 229
Canada Vigilance: 5
Canada Vigilance
US FAERS
4ThrombosisFAERS: 214
Canada Vigilance: 4
Canada Vigilance
US FAERS
5HeadacheFAERS: 212
Canada Vigilance: 5
Canada Vigilance
US FAERS
6Cerebrovascular accidentFAERS: 209
Canada Vigilance: 2
Canada Vigilance
US FAERS
7Feeling abnormalFAERS: 179
Canada Vigilance: 4
Canada Vigilance
US FAERS
8Product quality issueFAERS: 178US FAERS
9Product use issueFAERS: 169
Canada Vigilance: 2
Canada Vigilance
US FAERS
10PainFAERS: 137
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
11Urinary tract infectionFAERS: 137
Canada Vigilance: 1
Canada Vigilance
US FAERS
12Vulvovaginal discomfortFAERS: 137US FAERS
13Vulvovaginal pruritusFAERS: 120
Canada Vigilance: 1
Canada Vigilance
US FAERS
14AlopeciaFAERS: 110
Canada Vigilance: 2
Canada Vigilance
US FAERS
15Intentional product misuseFAERS: 109
Canada Vigilance: 1
Canada Vigilance
US FAERS
16NauseaFAERS: 107
Canada Vigilance: 4
Canada Vigilance
US FAERS
17Vulvovaginal painFAERS: 101
Canada Vigilance: 2
Canada Vigilance
US FAERS
18Myocardial InfarctionFAERS: 100
Canada Vigilance: 2
Canada Vigilance
US FAERS
19PruritusFAERS: 96
Canada Vigilance: 3
Canada Vigilance
US FAERS
20DizzinessFAERS: 95
Canada Vigilance: 3
Canada Vigilance
US FAERS
21FatigueFAERS: 87
Canada Vigilance: 3
Canada Vigilance
US FAERS
22Burning sensationFAERS: 84US FAERS
23Product use in unapproved indicationFAERS: 80US FAERS
24Pulmonary EmbolismFAERS: 79
Canada Vigilance: 5
Canada Vigilance
US FAERS
25HypersensitivityFAERS: 75
Canada Vigilance: 1
Canada Vigilance
US FAERS
26AnxietyFAERS: 72OFFSIDES
US FAERS
27NervousnessFAERS: 71
Canada Vigilance: 1
Canada Vigilance
US FAERS
28Night sweatsFAERS: 70US FAERS
29Drug ineffective for unapproved indicationFAERS: 62US FAERS
30Vulvovaginal mycotic infectionFAERS: 62US FAERS
31Therapeutic response unexpectedFAERS: 60
Canada Vigilance: 1
Canada Vigilance
US FAERS
32Vulvovaginal drynessFAERS: 60US FAERS
33AstheniaFAERS: 57
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
US FAERS
34Drug effect incompleteFAERS: 57US FAERS
35Breast tendernessFAERS: 52
Canada Vigilance: 3
Canada Vigilance
US FAERS
36Emotional disorderFAERS: 52US FAERS
37Abdominal PainFAERS: 50
Canada Vigilance: 1
Canada Vigilance
US FAERS
38Back PainFAERS: 50US FAERS
39Incorrect dose administeredFAERS: 48
Canada Vigilance: 1
Canada Vigilance
US FAERS
40Memory impairmentFAERS: 48
Canada Vigilance: 1
Canada Vigilance
US FAERS
41CystitisFAERS: 47US FAERS
42Chest PainFAERS: 46OFFSIDES
US FAERS
43Deep Vein ThrombosisFAERS: 46
Canada Vigilance: 1
Canada Vigilance
US FAERS
44Mood swingsFAERS: 45US FAERS
45NasopharyngitisFAERS: 45US FAERS
46Weight decreasedFAERS: 44
Canada Vigilance: 3
Canada Vigilance
US FAERS
47Pre-existing condition improvedFAERS: 43US FAERS
48Wrong technique in product usage processFAERS: 43
Canada Vigilance: 2
Canada Vigilance
US FAERS
49CryingFAERS: 42
Canada Vigilance: 2
Canada Vigilance
US FAERS
50Expired product administeredFAERS: 40US FAERS
51Application site painFAERS: 39
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
52Drug dose omissionFAERS: 39US FAERS
53InfectionFAERS: 39OFFSIDES
US FAERS
54TremorFAERS: 38
Canada Vigilance: 1
Canada Vigilance
US FAERS
55UrticariaFAERS: 38
Canada Vigilance: 1
Canada Vigilance
US FAERS
56Vulvovaginal swellingFAERS: 38
Canada Vigilance: 1
Canada Vigilance
US FAERS
57ArthritisFAERS: 37US FAERS
58DiscomfortFAERS: 36
Canada Vigilance: 1
Canada Vigilance
US FAERS
59Hormone level abnormalFAERS: 35US FAERS
60Contralateral breast cancerFAERS: 34OFFSIDES
US FAERS
61SwellingFAERS: 34
Canada Vigilance: 1
Canada Vigilance
US FAERS
62Breast cancer recurrentFAERS: 33
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
63Poor quality drug administeredFAERS: 33US FAERS
64StressFAERS: 33US FAERS
65Vaginal DischargeFAERS: 33
Canada Vigilance: 1
Canada Vigilance
US FAERS
66DementiaFAERS: 31US FAERS
67Diabetes MellitusFAERS: 31US FAERS
68Drug withdrawal syndromeFAERS: 31US FAERS
69DyspareuniaFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
70PalpitationsFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
71ArthropathyFAERS: 29US FAERS
72ErythemaFAERS: 28US FAERS
73Depressed moodFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
74InfluenzaFAERS: 27US FAERS
75Abdominal discomfortFAERS: 26
Canada Vigilance: 1
Canada Vigilance
US FAERS
76AmnesiaFAERS: 26US FAERS
77DysuriaFAERS: 26US FAERS
78Dry skinFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
79Visual ImpairmentFAERS: 25
Canada Vigilance: 3
Canada Vigilance
US FAERS
80Vulvovaginal erythemaFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
81Intentional product use issueFAERS: 24US FAERS
82OsteoporosisFAERS: 24US FAERS
83Suspected counterfeit productFAERS: 24US FAERS
84Pelvic PainFAERS: 23US FAERS
85VomitingFAERS: 23
Canada Vigilance: 2
Canada Vigilance
US FAERS
86AsthmaFAERS: 21OFFSIDES
US FAERS
87Inappropriate schedule of drug administrationFAERS: 21US FAERS
88Blood cholesterol increasedFAERS: 20US FAERS
89Drug effect delayedFAERS: 20US FAERS
90Urinary IncontinenceFAERS: 20US FAERS
91Wrong technique in drug usage processFAERS: 20US FAERS
92Uterine CancerFAERS: 19
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
93Medication residueFAERS: 18US FAERS
94PneumoniaFAERS: 18US FAERS
95ArthralgiaFAERS: 16US FAERS
96Drug dispensing errorFAERS: 16US FAERS
97DyspepsiaFAERS: 16OFFSIDES
US FAERS
98Joint swellingFAERS: 16US FAERS
99Limb injuryFAERS: 16US FAERS
100AngerFAERS: 15US FAERS
101Bladder prolapseFAERS: 15OFFSIDES
US FAERS
102Breast CystFAERS: 15OFFSIDES
US FAERS
103DeafnessFAERS: 15
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
104No adverse eventFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
105Skin irritationFAERS: 15US FAERS
106AcneFAERS: 14US FAERS
107CataractFAERS: 13OFFSIDES
US FAERS
108ConstipationFAERS: 13US FAERS
109Pharmaceutical product complaintFAERS: 13US FAERS
110Product complaintFAERS: 13
Canada Vigilance: 14
Canada Vigilance
US FAERS
111Application site irritationFAERS: 12US FAERS
112FibromyalgiaFAERS: 12US FAERS
113Nipple painFAERS: 12OFFSIDES
US FAERS
114Peripheral swellingFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
115AgitationFAERS: 11US FAERS
116Chest discomfortFAERS: 11US FAERS
117ChillsFAERS: 11
Canada Vigilance: 2
Canada Vigilance
US FAERS
118Contraindicated product administeredFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
119DysphoniaFAERS: 11US FAERS
120Expired drug administeredFAERS: 11US FAERS
121Limb discomfortFAERS: 11OFFSIDES
US FAERS
122Medication residue presentFAERS: 11US FAERS
123Atrophic vulvovaginitisFAERS: 10OFFSIDES
US FAERS
124Back disorderFAERS: 10US FAERS
125BlindnessFAERS: 10US FAERS
126Circumstance or information capable of leading to medication errorFAERS: 10US FAERS
127Drug administered at inappropriate siteFAERS: 10US FAERS
128Drug prescribing errorFAERS: 10US FAERS
129Feeling ColdFAERS: 10US FAERS
130Feeling jitteryFAERS: 10US FAERS
131FlatulenceFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
132Intentional drug misuseFAERS: 10US FAERS
133MalabsorptionFAERS: 10US FAERS
134MenorrhagiaFAERS: 10
Canada Vigilance: 4
Canada Vigilance
US FAERS
135MetrorrhagiaFAERS: 10US FAERS
136Vaginal ProlapseFAERS: 10OFFSIDES
US FAERS
137Activities of daily living impairedFAERS: 9US FAERS
138Bone density decreasedFAERS: 9US FAERS
139BronchitisFAERS: 9
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
140Drug effective for unapproved indicationFAERS: 9US FAERS
141Exposure via partnerFAERS: 9US FAERS
142FrustrationFAERS: 9US FAERS
143Impaired driving abilityFAERS: 9US FAERS
144LaryngitisFAERS: 9US FAERS
145Muscle tightnessFAERS: 9US FAERS
146Product prescribing errorFAERS: 9US FAERS
147Rash erythematousFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
148SinusitisFAERS: 9OFFSIDES
US FAERS
149TinnitusFAERS: 9OFFSIDES
US FAERS
150Unevaluable eventFAERS: 9US FAERS
151Vaginal erosionFAERS: 9US FAERS
152Vulvovaginal rashFAERS: 9US FAERS
153nervous system disorderFAERS: 9US FAERS
154Accidental exposureFAERS: 8US FAERS
155AdenocarcinomaFAERS: 8OFFSIDES
US FAERS
156Blood glucose increasedFAERS: 8US FAERS
157Bone painFAERS: 8US FAERS
158Drug administration errorFAERS: 8US FAERS
159EndometriosisFAERS: 8US FAERS
160Joint injuryFAERS: 8OFFSIDES
US FAERS
161Middle insomniaFAERS: 8US FAERS
162MyalgiaFAERS: 8US FAERS
163Oropharyngeal painFAERS: 8US FAERS
164Reaction to drug excipientsFAERS: 8US FAERS
165Vaginal mucosal blisteringFAERS: 8US FAERS
166WheezingFAERS: 8US FAERS
167Adnexa uteri painFAERS: 7US FAERS
168Application site discomfortFAERS: 7US FAERS
169Application site erythemaFAERS: 7US FAERS
170Atrial FibrillationFAERS: 7US FAERS
171CholelithiasisFAERS: 7US FAERS
172DysgeusiaFAERS: 7US FAERS
173FlushingFAERS: 7US FAERS
174Medication ErrorFAERS: 7US FAERS
175Musculoskeletal stiffnessFAERS: 7US FAERS
176Nonspecific reactionFAERS: 7OFFSIDES
US FAERS
177Poor quality sleepFAERS: 7US FAERS
178Precocious PubertyFAERS: 7US FAERS
179Product dispensing errorFAERS: 7US FAERS
180Product dose omissionFAERS: 7US FAERS
181Product physical issueFAERS: 7US FAERS
182Rheumatoid ArthritisFAERS: 7US FAERS
183SomnolenceFAERS: 7US FAERS
184TachycardiaFAERS: 7US FAERS
185Uterine spasmFAERS: 7US FAERS
186Accidental exposure to productFAERS: 6US FAERS
187Application site swellingFAERS: 6US FAERS
188Blood urine presentFAERS: 6US FAERS
189Coronary Artery DiseaseFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
190Drug DependenceFAERS: 6US FAERS
191Endometrial HyperplasiaFAERS: 6
Canada Vigilance: 42
Canada Vigilance
US FAERS
192General physical health deteriorationFAERS: 6US FAERS
193GlaucomaFAERS: 6US FAERS
194Head discomfortFAERS: 6US FAERS
195HypothyroidismFAERS: 6US FAERS
196Intestinal ObstructionFAERS: 6US FAERS
197MeningiomaFAERS: 6US FAERS
198Metastatic NeoplasmFAERS: 6US FAERS
199Sexual DysfunctionFAERS: 6US FAERS
200Skin lesionFAERS: 6US FAERS
201SyncopeFAERS: 6US FAERS
202Therapeutic response changedFAERS: 6US FAERS
203Throat irritationFAERS: 6US FAERS
204furuncleFAERS: 6US FAERS
205AneurysmFAERS: 5OFFSIDES
US FAERS
206Anorectal discomfortFAERS: 5US FAERS
207AphoniaFAERS: 5US FAERS
208Bacterial VaginosisFAERS: 5US FAERS
209Blood cholesterol abnormalFAERS: 5US FAERS
210Blood triglycerides increasedFAERS: 5US FAERS
211Cerebral InfarctionFAERS: 5US FAERS
212Cerebral ThrombosisFAERS: 5US FAERS
213ChromaturiaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
214Cold sweatFAERS: 5US FAERS
215ColitisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
216DisorientationFAERS: 5US FAERS
217Drug administered to patient of inappropriate ageFAERS: 5US FAERS
218Erectile dysfunctionFAERS: 5US FAERS
219HirsutismFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
220HysterectomyFAERS: 5OFFSIDES
US FAERS
221InflammationFAERS: 5US FAERS
222Intervertebral Disc DegenerationFAERS: 5OFFSIDES
US FAERS
223Irritable Bowel SyndromeFAERS: 5US FAERS
224LethargyFAERS: 5US FAERS
225Macular degenerationFAERS: 5US FAERS
226MenopauseFAERS: 5US FAERS
227Musculoskeletal PainFAERS: 5US FAERS
228Musculoskeletal discomfortFAERS: 5US FAERS
229NephrolithiasisFAERS: 5US FAERS
230OverdoseFAERS: 5US FAERS
231Pelvic prolapseFAERS: 5
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
232Precancerous skin lesionFAERS: 5OFFSIDES
US FAERS
233PresyncopeFAERS: 5US FAERS
234Product contaminationFAERS: 5US FAERS
235RestlessnessFAERS: 5US FAERS
236Retinal DetachmentFAERS: 5US FAERS
237UlcerFAERS: 5US FAERS
238Urinary RetentionFAERS: 5US FAERS
239VertigoFAERS: 5US FAERS
240jaundiceFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
241AbasiaFAERS: 4US FAERS
242Application site hypersensitivityFAERS: 4US FAERS
243Application site pruritusFAERS: 4US FAERS
244Bacterial vulvovaginitisFAERS: 4US FAERS
245Bipolar DisorderFAERS: 4US FAERS
246Bladder painFAERS: 4US FAERS
247Blood testosterone abnormalFAERS: 4US FAERS
248Breast cancer stage IIFAERS: 4US FAERS
249Cells in urineFAERS: 4US FAERS
250CystFAERS: 4US FAERS
251DehydrationFAERS: 4OFFSIDES
US FAERS
252Disease ProgressionFAERS: 4US FAERS
253Disease recurrenceFAERS: 4US FAERS
254EczemaFAERS: 4US FAERS
255Endometrial hypertrophyFAERS: 4US FAERS
256EpilepsyFAERS: 4US FAERS
257Food AllergyFAERS: 4US FAERS
258FractureFAERS: 4US FAERS
259Genital burning sensationFAERS: 4US FAERS
260HyperthyroidismFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
261IncontinenceFAERS: 4OFFSIDES
US FAERS
262LymphadenopathyFAERS: 4US FAERS
263Malabsorption from application siteFAERS: 4US FAERS
264Mental impairmentFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
265Multiple SclerosisFAERS: 4OFFSIDES
US FAERS
266Obsessive-Compulsive DisorderFAERS: 4US FAERS
267OnychoclasisFAERS: 4US FAERS
268PancreatitisFAERS: 4US FAERS
269PhlebitisFAERS: 4
Canada Vigilance: 3
Canada Vigilance
US FAERS
270Post procedural complicationFAERS: 4OFFSIDES
US FAERS
271Precancerous cells presentFAERS: 4US FAERS
272Product counterfeitFAERS: 4US FAERS
273Product packaging quantity issueFAERS: 4US FAERS
274Product taste abnormalFAERS: 4US FAERS
275Pulmonary thrombosisFAERS: 4US FAERS
276SepsisFAERS: 4US FAERS
277Thermal burnFAERS: 4US FAERS
278UnderweightFAERS: 4US FAERS
279Uterine ProlapseFAERS: 4OFFSIDES
US FAERS
280Vaginal lesionFAERS: 4US FAERS
281Accidental exposure to product by childFAERS: 3US FAERS
282Ankle FractureFAERS: 3US FAERS
283Bacterial test positiveFAERS: 3OFFSIDES
US FAERS
284Blood count abnormalFAERS: 3US FAERS
285Blood glucose abnormalFAERS: 3US FAERS
286Breast cancer stage IIIFAERS: 3OFFSIDES
US FAERS
287Cardiac ArrestFAERS: 3US FAERS
288Carotid Artery ThrombosisFAERS: 3OFFSIDES
US FAERS
289Carotid artery occlusionFAERS: 3US FAERS
290ChloasmaFAERS: 3US FAERS
291DiplopiaFAERS: 3OFFSIDES
US FAERS
292DiverticulitisFAERS: 3OFFSIDES
US FAERS
293DysgraphiaFAERS: 3US FAERS
294Endometrial disorderFAERS: 3OFFSIDES
US FAERS
295EpistaxisFAERS: 3US FAERS
296EructationFAERS: 3US FAERS
297Erythema MultiformeFAERS: 3US FAERS
298Eye painFAERS: 3US FAERS
299Feeling of body temperature changeFAERS: 3US FAERS
300FormicationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
301Gastric ulcerFAERS: 3US FAERS
302GastritisFAERS: 3US FAERS
303Gastrointestinal PainFAERS: 3US FAERS
304General physical condition abnormalFAERS: 3US FAERS
305Genital swellingFAERS: 3US FAERS
306Impaired work abilityFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
307Incorrect product storageFAERS: 3US FAERS
308Intentional dose omissionFAERS: 3US FAERS
309Intercepted drug dispensing errorFAERS: 3US FAERS
310Invasive Ductal Breast CarcinomaFAERS: 3US FAERS
311Joint stiffnessFAERS: 3US FAERS
312LabyrinthitisFAERS: 3US FAERS
313Lipids abnormalFAERS: 3US FAERS
314Loss of personal independence in daily activitiesFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
315Meniscus injuryFAERS: 3US FAERS
316MetastasisFAERS: 3US FAERS
317Muscle strainFAERS: 3US FAERS
318Nasal discomfortFAERS: 3US FAERS
319Neck PainFAERS: 3US FAERS
320NocturiaFAERS: 3OFFSIDES
US FAERS
321OsteopeniaFAERS: 3OFFSIDES
US FAERS
322Pancreatic carcinomaFAERS: 3US FAERS
323PolyarthritisFAERS: 3US FAERS
324Post-Traumatic Stress DisorderFAERS: 3US FAERS
325Premenstrual syndromeFAERS: 3US FAERS
326Product packaging issueFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
327Product prescribing issueFAERS: 3US FAERS
328Product solubility abnormalFAERS: 3US FAERS
329Radiation injuryFAERS: 3US FAERS
330Restless Legs SyndromeFAERS: 3US FAERS
331SciaticaFAERS: 3US FAERS
332SclerodermaFAERS: 3OFFSIDES
US FAERS
333Sexual relationship changeFAERS: 3US FAERS
334ShockFAERS: 3US FAERS
335Skin UlcerFAERS: 3US FAERS
336Skin WrinklingFAERS: 3US FAERS
337SneezingFAERS: 3US FAERS
338Spinal column stenosisFAERS: 3OFFSIDES
US FAERS
339StomatitisFAERS: 3US FAERS
340Therapeutic product effect incompleteFAERS: 3
Canada Vigilance: 7
Canada Vigilance
US FAERS
341Thrombotic strokeFAERS: 3US FAERS
342Uterine inflammationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
343Viral upper respiratory tract infectionFAERS: 3US FAERS
344Wrong drug administeredFAERS: 3US FAERS
345Abdominal tendernessFAERS: 2US FAERS
346Abdominal wound dehiscenceFAERS: 2US FAERS
347Acoustic NeuromaFAERS: 2OFFSIDES
US FAERS
348Allergic reaction to excipientFAERS: 2US FAERS
349Altered state of consciousnessFAERS: 2US FAERS
350Antinuclear antibody increasedFAERS: 2US FAERS
351AphasiaFAERS: 2US FAERS
352Apparent deathFAERS: 2US FAERS
353Application site rashFAERS: 2US FAERS
354Application site reactionFAERS: 2US FAERS
355BedriddenFAERS: 2US FAERS
356Blood potassium decreasedFAERS: 2OFFSIDES
US FAERS
357Blood pressure inadequately controlledFAERS: 2US FAERS
358Breast discomfortFAERS: 2US FAERS
359Breast fibromaFAERS: 2US FAERS
360Breast hyperplasiaFAERS: 2OFFSIDES
US FAERS
361CarcinomaFAERS: 2US FAERS
362Cerebral disorderFAERS: 2US FAERS
363Cervical dysplasiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
364CheilitisFAERS: 2US FAERS
365ChokingFAERS: 2US FAERS
366ChoreaFAERS: 2US FAERS
367Citrobacter infectionFAERS: 2US FAERS
368Coital bleedingFAERS: 2US FAERS
369Counterfeit drug administeredFAERS: 2US FAERS
370DissociationFAERS: 2US FAERS
371Dissociative AmnesiaFAERS: 2US FAERS
372Ear discomfortFAERS: 2US FAERS
373Ectopic PregnancyFAERS: 2US FAERS
374Emotional distressFAERS: 2US FAERS
375ExcoriationFAERS: 2OFFSIDES
US FAERS
376Extra dose administeredFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
377Eye irritationFAERS: 2US FAERS
378Gait inabilityFAERS: 2US FAERS
379Genital rashFAERS: 2OFFSIDES
US FAERS
380HemiparesisFAERS: 2US FAERS
381HepatitisFAERS: 2US FAERS
382HerniaFAERS: 2US FAERS
383HostilityFAERS: 2US FAERS
384HydrocephalusFAERS: 2OFFSIDES
US FAERS
385HypersomniaFAERS: 2US FAERS
386HypertrichosisFAERS: 2US FAERS
387Hypothalamo-pituitary disorderFAERS: 2US FAERS
388IleusFAERS: 2US FAERS
389Incorrect route of drug administrationFAERS: 2US FAERS
390Intestinal cystFAERS: 2US FAERS
391Lip swellingFAERS: 2US FAERS
392LipomaFAERS: 2US FAERS
393Lyme DiseaseFAERS: 2US FAERS
394LymphangioleiomyomatosisFAERS: 2US FAERS
395LymphomaFAERS: 2US FAERS
396MalnutritionFAERS: 2US FAERS
397MastitisFAERS: 2US FAERS
398Metastatic uterine cancerFAERS: 2US FAERS
399Micturition frequency decreasedFAERS: 2US FAERS
400Migraine with AuraFAERS: 2OFFSIDES
US FAERS
401MonoplegiaFAERS: 2US FAERS
402Multiple allergiesFAERS: 2US FAERS
403Muscle CrampFAERS: 2US FAERS
404Muscle RigidityFAERS: 2US FAERS
405Musculoskeletal chest painFAERS: 2OFFSIDES
US FAERS
406NeuralgiaFAERS: 2US FAERS
407Oral candidiasisFAERS: 2US FAERS
408Oral fungal infectionFAERS: 2US FAERS
409Oropharyngeal discomfortFAERS: 2US FAERS
410OsteomyelitisFAERS: 2OFFSIDES
US FAERS
411ParanoiaFAERS: 2US FAERS
412Penile burning sensationFAERS: 2US FAERS
413Personality ChangeFAERS: 2US FAERS
414PertussisFAERS: 2US FAERS
415PetechiaeFAERS: 2US FAERS
416Pharmaceutical product counterfeitFAERS: 2US FAERS
417PhotophobiaFAERS: 2US FAERS
418Poor quality product administeredFAERS: 2US FAERS
419Product leakageFAERS: 2US FAERS
420Product physical consistency issueFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
421Product preparation errorFAERS: 2US FAERS
422PsoriasisFAERS: 2US FAERS
423Pulmonary HypertensionFAERS: 2OFFSIDES
US FAERS
424PyelocaliectasisFAERS: 2US FAERS
425Quality of life decreasedFAERS: 2US FAERS
426Respiratory arrestFAERS: 2US FAERS
427Rotator cuff syndromeFAERS: 2US FAERS
428ScabFAERS: 2US FAERS
429ScreamingFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
430Sinus ArrhythmiaFAERS: 2US FAERS
431Sinus headacheFAERS: 2OFFSIDES
US FAERS
432Skin ErosionFAERS: 2OFFSIDES
US FAERS
433Skin reactionFAERS: 2US FAERS
434Skin test positiveFAERS: 2US FAERS
435SluggishnessFAERS: 2US FAERS
436SplenomegalyFAERS: 2US FAERS
437SunburnFAERS: 2US FAERS
438Tension HeadacheFAERS: 2OFFSIDES
US FAERS
439Therapeutic response unexpected with drug substitutionFAERS: 2US FAERS
440Tissue injuryFAERS: 2US FAERS
441ToothacheFAERS: 2US FAERS
442TrichorrhexisFAERS: 2OFFSIDES
US FAERS
443Triple vessel bypass graftFAERS: 2US FAERS
444TuberculosisFAERS: 2US FAERS
445UrethritisFAERS: 2US FAERS
446Urinary tract infection fungalFAERS: 2US FAERS
447Urinary tract inflammationFAERS: 2US FAERS
448Vaginal burning sensationFAERS: 2US FAERS
449Vitamin D DeficiencyFAERS: 2US FAERS
450Vulvovaginal injuryFAERS: 2US FAERS
451White blood cell count decreasedFAERS: 2US FAERS
452Wound ComplicationFAERS: 2US FAERS
453fibromaFAERS: 2OFFSIDES
US FAERS
454Abdominal rigidityFAERS: 1US FAERS
455Accidental overdoseFAERS: 1US FAERS
456Acquired cardiac septal defectFAERS: 1US FAERS
457Acute myocardial infarctionFAERS: 1US FAERS
458Adenoid Cystic CarcinomaFAERS: 1US FAERS
459Adrenocortical insufficiency chronicFAERS: 1US FAERS
460Adverse eventFAERS: 1US FAERS
461Allergy to chemicalsFAERS: 1US FAERS
462Ammonia increasedFAERS: 1OFFSIDES
US FAERS
463Anal inflammationFAERS: 1US FAERS
464Anaphylactoid ReactionFAERS: 1US FAERS
465Angina PectorisFAERS: 1US FAERS
466AnhedoniaFAERS: 1US FAERS
467AnhidrosisFAERS: 1US FAERS
468AnorgasmiaFAERS: 1US FAERS
469Antiphospholipid AntibodiesFAERS: 1US FAERS
470Antiphospholipid antibodies positiveFAERS: 1OFFSIDES
US FAERS
471Aortic AneurysmFAERS: 1US FAERS
472Aortic RuptureFAERS: 1US FAERS
473ApathyFAERS: 1US FAERS
474AppendicitisFAERS: 1US FAERS
475Application site drynessFAERS: 1US FAERS
476Application site erosionFAERS: 1US FAERS
477ArteriosclerosisFAERS: 1OFFSIDES
US FAERS
478Arthropod biteFAERS: 1US FAERS
479Arthropod stingFAERS: 1US FAERS
480Atrioventricular BlockFAERS: 1US FAERS
481Autoimmune thyroiditisFAERS: 1US FAERS
482Benign female reproductive tract neoplasmFAERS: 1US FAERS
483Bile output increasedFAERS: 1US FAERS
484Biopsy endometrium abnormalFAERS: 1US FAERS
485Bipolar I disorderFAERS: 1US FAERS
486Bladder NeoplasmFAERS: 1US FAERS
487Bladder neck obstructionFAERS: 1US FAERS
488Bladder spasmFAERS: 1US FAERS
489Blood albumin decreasedFAERS: 1OFFSIDES
US FAERS
490Blood alkaline phosphatase increasedFAERS: 1US FAERS
491Blood creatinine increasedFAERS: 1US FAERS
492Blood follicle stimulating hormone increasedFAERS: 1US FAERS
493Blood glucose fluctuationFAERS: 1US FAERS
494Blood iron decreasedFAERS: 1US FAERS
495Blood potassium abnormalFAERS: 1US FAERS
496Blood testosterone decreasedFAERS: 1US FAERS
497Blood thyroid stimulating hormone abnormalFAERS: 1US FAERS
498Bone scan abnormalFAERS: 1OFFSIDES
US FAERS
499Bowel movement irregularityFAERS: 1US FAERS
500Breakthrough PainFAERS: 1US FAERS
501Breast MicrocalcificationFAERS: 1OFFSIDES
US FAERS
502Breast engorgementFAERS: 1US FAERS
503CD4 Lymphocytes DecreasedFAERS: 1US FAERS
504Capillary FragilityFAERS: 1US FAERS
505Carbon dioxide increasedFAERS: 1US FAERS
506Cardiac FlutterFAERS: 1OFFSIDES
US FAERS
507CardiomegalyFAERS: 1US FAERS
508Carpal Tunnel SyndromeFAERS: 1US FAERS
509Cartilage injuryFAERS: 1US FAERS
510Cerebral aneurysm perforationFAERS: 1US FAERS
511Cervix carcinomaFAERS: 1US FAERS
512Chemical injuryFAERS: 1US FAERS
513ChloropsiaFAERS: 1US FAERS
514Choking sensationFAERS: 1US FAERS
515CholecystitisFAERS: 1US FAERS
516CholestasisFAERS: 1US FAERS
517Chronic Fatigue SyndromeFAERS: 1US FAERS
518Colon adenomaFAERS: 1OFFSIDES
US FAERS
519Colostomy infectionFAERS: 1US FAERS
520Compression fractureFAERS: 1US FAERS
521Contact lens intoleranceFAERS: 1US FAERS
522Contraindicated drug administeredFAERS: 1US FAERS
523Conversion disorderFAERS: 1US FAERS
524Counterfeit product administeredFAERS: 1US FAERS
525Cystitis escherichiaFAERS: 1US FAERS
526Cystitis-like symptomFAERS: 1US FAERS
527CystoceleFAERS: 1OFFSIDES
US FAERS
528Decreased immune responsivenessFAERS: 1US FAERS
529Degeneration of uterine fibroidFAERS: 1US FAERS
530DependenceFAERS: 1US FAERS
531Dermal absorption impairedFAERS: 1US FAERS
532Device breakageFAERS: 1US FAERS
533DisabilityFAERS: 1US FAERS
534Drug effect variableFAERS: 1US FAERS
535Drug exposure during pregnancyFAERS: 1US FAERS
536Drug withdrawal headacheFAERS: 1US FAERS
537DysarthriaFAERS: 1US FAERS
538DystoniaFAERS: 1OFFSIDES
US FAERS
539Economic problemFAERS: 1OFFSIDES
US FAERS
540Electrocardiogram abnormalFAERS: 1US FAERS
541Endodontic procedureFAERS: 1OFFSIDES
US FAERS
542Endometrial adenocarcinomaFAERS: 1
Canada Vigilance: 5
Canada Vigilance
US FAERS
543Endometrial cancer stage IIIFAERS: 1US FAERS
544Endometrial thickeningFAERS: 1US FAERS
545Enterocutaneous FistulaFAERS: 1US FAERS
546Epigastric discomfortFAERS: 1US FAERS
547Erythema NodosumFAERS: 1US FAERS
548Escherichia infectionFAERS: 1OFFSIDES
US FAERS
549Escherichia test positiveFAERS: 1US FAERS
550Escherichia urinary tract infectionFAERS: 1US FAERS
551Euphoric moodFAERS: 1OFFSIDES
US FAERS
552ExtravasationFAERS: 1US FAERS
553Eye InfectionFAERS: 1OFFSIDES
US FAERS
554Eye inflammationFAERS: 1OFFSIDES
US FAERS
555Eyelids pruritusFAERS: 1US FAERS
556False positive investigation resultFAERS: 1US FAERS
557Flank PainFAERS: 1US FAERS
558Food cravingFAERS: 1US FAERS
559GastroenteritisFAERS: 1OFFSIDES
US FAERS
560Gastrointestinal carcinomaFAERS: 1US FAERS
561Gastrointestinal infectionFAERS: 1US FAERS
562Gastrointestinal obstructionFAERS: 1US FAERS
563Genital erythemaFAERS: 1OFFSIDES
US FAERS
564Genital tract inflammationFAERS: 1US FAERS
565GliomaFAERS: 1US FAERS
566Grip strength decreasedFAERS: 1US FAERS
567Growth failureFAERS: 1US FAERS
568Head titubationFAERS: 1US FAERS
569Heart valve stenosisFAERS: 1US FAERS
570Heat StrokeFAERS: 1OFFSIDES
US FAERS
571HemiplegiaFAERS: 1US FAERS
572Hepatitis BFAERS: 1US FAERS
573Hepatitis CFAERS: 1OFFSIDES
US FAERS
574HepatomegalyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
575HepatotoxicityFAERS: 1US FAERS
576High density lipoprotein increasedFAERS: 1US FAERS
577HydrometraFAERS: 1US FAERS
578HyperkeratosisFAERS: 1US FAERS
579HyperphagiaFAERS: 1US FAERS
580HyperplasiaFAERS: 1US FAERS
581HyperventilationFAERS: 1US FAERS
582Impaired gastric emptyingFAERS: 1US FAERS
583Implant site reactionFAERS: 1OFFSIDES
US FAERS
584Inappropriate schedule of product administrationFAERS: 1US FAERS
585Incision site complicationFAERS: 1US FAERS
586Incision site pruritusFAERS: 1US FAERS
587Incisional herniaFAERS: 1OFFSIDES
US FAERS
588Incorrect dose administered by deviceFAERS: 1US FAERS
589Incorrect route of product administrationFAERS: 1US FAERS
590Incorrect storage of drugFAERS: 1US FAERS
591Increased upper airway secretionFAERS: 1US FAERS
592IndurationFAERS: 1US FAERS
593InfarctionFAERS: 1US FAERS
594Infected varicose veinFAERS: 1US FAERS
595Injection site inflammationFAERS: 1US FAERS
596Injury asphyxiationFAERS: 1US FAERS
597Insulin-like growth factor decreasedFAERS: 1US FAERS
598Intercepted drug prescribing errorFAERS: 1US FAERS
599Intermittent ClaudicationFAERS: 1OFFSIDES
US FAERS
600Intervertebral disc disorderFAERS: 1OFFSIDES
US FAERS
601Intervertebral disc injuryFAERS: 1US FAERS
602Joint prosthesis userFAERS: 1US FAERS
603Lack of spontaneous speechFAERS: 1US FAERS
604Lactose IntoleranceFAERS: 1OFFSIDES
US FAERS
605LazinessFAERS: 1US FAERS
606Lichen PlanusFAERS: 1OFFSIDES
US FAERS
607Ligament painFAERS: 1US FAERS
608Ligament ruptureFAERS: 1US FAERS
609Limb crushing injuryFAERS: 1US FAERS
610Lipoma of breastFAERS: 1OFFSIDES
US FAERS
611Low density lipoprotein increasedFAERS: 1US FAERS
612LymphoceleFAERS: 1US FAERS
613Malabsorption from administration siteFAERS: 1US FAERS
614Malignant neoplasm progressionFAERS: 1US FAERS
615MastectomyFAERS: 1OFFSIDES
US FAERS
616Maternal exposure during pregnancyFAERS: 1US FAERS
617MeningitisFAERS: 1US FAERS
618Menstrual discomfortFAERS: 1US FAERS
619Mental status changesFAERS: 1OFFSIDES
US FAERS
620MetamorphopsiaFAERS: 1US FAERS
621Metastases to muscleFAERS: 1OFFSIDES
US FAERS
622Metastases to perineumFAERS: 1US FAERS
623MiliariaFAERS: 1US FAERS
624Mouth swellingFAERS: 1US FAERS
625Moyamoya DiseaseFAERS: 1US FAERS
626Muscle FatigueFAERS: 1US FAERS
627MutismFAERS: 1US FAERS
628NephritisFAERS: 1US FAERS
629Nephrotic SyndromeFAERS: 1US FAERS
630Nerve injuryFAERS: 1US FAERS
631NeutropeniaFAERS: 1US FAERS
632ObesityFAERS: 1US FAERS
633Ocular icterusFAERS: 1OFFSIDES
US FAERS
634Oral mucosal erythemaFAERS: 1OFFSIDES
US FAERS
635Oral painFAERS: 1US FAERS
636Oral pruritusFAERS: 1OFFSIDES
US FAERS
637Orgasmic sensation decreasedFAERS: 1US FAERS
638Oropharyngeal blisteringFAERS: 1US FAERS
639Oropharyngeal plaqueFAERS: 1OFFSIDES
US FAERS
640Orthostatic tremorFAERS: 1US FAERS
641Osteitis DeformansFAERS: 1OFFSIDES
US FAERS
642OtosclerosisFAERS: 1US FAERS
643OverweightFAERS: 1US FAERS
644PO2 decreasedFAERS: 1US FAERS
645PallorFAERS: 1US FAERS
646Panic DisorderFAERS: 1OFFSIDES
US FAERS
647PapuleFAERS: 1US FAERS
648Paraesthesia of genital femaleFAERS: 1US FAERS
649Paranoid Personality DisorderFAERS: 1US FAERS
650Pelvic Floor Muscle WeaknessFAERS: 1US FAERS
651Pelvic InfectionFAERS: 1US FAERS
652Penile size reducedFAERS: 1US FAERS
653Pericardial effusionFAERS: 1US FAERS
654Peripheral arterial occlusive diseaseFAERS: 1US FAERS
655Persistent genital arousal disorderFAERS: 1US FAERS
656Pharyngolaryngeal PainFAERS: 1US FAERS
657PiloerectionFAERS: 1US FAERS
658Pleuritic painFAERS: 1US FAERS
659PolyneuropathyFAERS: 1US FAERS
660Porphyria non-acuteFAERS: 1OFFSIDES
US FAERS
661Portal Vein ThrombosisFAERS: 1US FAERS
662Positron emission tomogram abnormalFAERS: 1OFFSIDES
US FAERS
663PrehypertensionFAERS: 1US FAERS
664Premature MenopauseFAERS: 1US FAERS
665Prescribed overdoseFAERS: 1US FAERS
666Prescription form tamperingFAERS: 1US FAERS
667Procedural complicationFAERS: 1US FAERS
668Product blister packaging issueFAERS: 1US FAERS
669Product container issueFAERS: 1US FAERS
670Product container seal issueFAERS: 1US FAERS
671Product contamination physicalFAERS: 1US FAERS
672Product expiration date issueFAERS: 1US FAERS
673Product formulation issueFAERS: 1US FAERS
674Product label confusionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
675Product packaging confusionFAERS: 1US FAERS
676Product residue presentFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
677Product selection errorFAERS: 1US FAERS
678Product shape issueFAERS: 1US FAERS
679Product size issueFAERS: 1US FAERS
680Protein urine presentFAERS: 1US FAERS
681Pubic painFAERS: 1US FAERS
682Pulmonary FibrosisFAERS: 1US FAERS
683Pulmonary InfarctionFAERS: 1US FAERS
684Pulmonary congestionFAERS: 1OFFSIDES
US FAERS
685PyuriaFAERS: 1OFFSIDES
US FAERS
686Reaction to excipientFAERS: 1US FAERS
687Reaction to preservativesFAERS: 1US FAERS
688Rectal ProlapseFAERS: 1OFFSIDES
US FAERS
689Rectal injuryFAERS: 1US FAERS
690RectoceleFAERS: 1OFFSIDES
US FAERS
691Rectosigmoid cancerFAERS: 1US FAERS
692Renal massFAERS: 1OFFSIDES
US FAERS
693Renal painFAERS: 1US FAERS
694Renal tubular necrosisFAERS: 1US FAERS
695Renin increasedFAERS: 1US FAERS
696Respiratory FailureFAERS: 1OFFSIDES
US FAERS
697RetinoblastomaFAERS: 1US FAERS
698RhinitisFAERS: 1US FAERS
699SLE arthritisFAERS: 1US FAERS
700SarcomaFAERS: 1US FAERS
701SchizophreniaFAERS: 1US FAERS
702Secretion dischargeFAERS: 1US FAERS
703Sensitive skinFAERS: 1US FAERS
704Sensory processing disorderFAERS: 1US FAERS
705Sexual activity increasedFAERS: 1US FAERS
706Skin PapillomaFAERS: 1US FAERS
707Skin tightnessFAERS: 1US FAERS
708Slow response to stimuliFAERS: 1US FAERS
709SoliloquyFAERS: 1US FAERS
710StrabismusFAERS: 1US FAERS
711Streptococcal urinary tract infectionFAERS: 1US FAERS
712Struck by lightningFAERS: 1US FAERS
713StuporFAERS: 1US FAERS
714Sudden deathFAERS: 1US FAERS
715Superficial vein prominenceFAERS: 1US FAERS
716Supraventricular tachycardiaFAERS: 1OFFSIDES
US FAERS
717Therapeutic product contaminationFAERS: 1US FAERS
718Therapeutic product ineffective for unapproved indicationFAERS: 1US FAERS
719Therapy cessationFAERS: 1US FAERS
720ThirstFAERS: 1US FAERS
721Throat cancerFAERS: 1US FAERS
722Thyroid NeoplasmFAERS: 1US FAERS
723Toe operationFAERS: 1US FAERS
724TonsillitisFAERS: 1US FAERS
725Tooth LossFAERS: 1OFFSIDES
US FAERS
726Toxicity to various agentsFAERS: 1US FAERS
727Trigeminal NeuralgiaFAERS: 1US FAERS
728Upper respiratory tract congestionFAERS: 1US FAERS
729Upper-airway cough syndromeFAERS: 1US FAERS
730Urethral StenosisFAERS: 1US FAERS
731Urethritis noninfectiveFAERS: 1US FAERS
732Urinary tract infection staphylococcalFAERS: 1US FAERS
733Urine alcohol test positiveFAERS: 1US FAERS
734Urine output increasedFAERS: 1US FAERS
735Uterine PolypFAERS: 1US FAERS
736Vaginal cancer recurrentFAERS: 1US FAERS
737Vaginal exfoliationFAERS: 1US FAERS
738Vaginal pH abnormalFAERS: 1US FAERS
739Vaginal painFAERS: 1US FAERS
740Vascular calcificationFAERS: 1US FAERS
741Vascular occlusionFAERS: 1US FAERS
742Vascular painFAERS: 1US FAERS
743Vascular ruptureFAERS: 1US FAERS
744VasospasmFAERS: 1OFFSIDES
US FAERS
745Venous thrombosis limbFAERS: 1US FAERS
746Visual disturbanceFAERS: 1US FAERS
747Vocal Cord ParalysisFAERS: 1OFFSIDES
US FAERS
748VulvitisFAERS: 1OFFSIDES
US FAERS
749Vulvovaginal wartsFAERS: 1US FAERS
750Wound dehiscenceFAERS: 1OFFSIDES
US FAERS
751Wrong doseFAERS: 1US FAERS
752Wrong technique in device usage processFAERS: 1US FAERS
753muscle injuryFAERS: 1US FAERS
754Abdominal adhesionsOFFSIDES
755Abnormal cervical smearOFFSIDES
756Acid refluxOFFSIDES
757Acquired porphyriaOFFSIDES
758Actinic keratosisOFFSIDES
759ActinomycosisOFFSIDES
760Acute bronchitisOFFSIDES
761Acute otitis mediaOFFSIDES
762AdenitisOFFSIDES
763AdenomaOFFSIDES
764Adrenal massOFFSIDES
765Alopecia effluviumOFFSIDES
766AlveolitisOFFSIDES
767Anti-erythropoietin antibody positiveOFFSIDES
768Anti-thyroid antibody positiveOFFSIDES
769Aortic valve sclerosisOFFSIDES
770ArachnoiditisOFFSIDES
771Arterial thrombosisOFFSIDES
772Arteriogram coronary abnormalOFFSIDES
773Arteriosclerosis ObliteransOFFSIDES
774ArteritisOFFSIDES
775Artificial crown procedureOFFSIDES
776Aspiration PneumoniaOFFSIDES
777AsterixisOFFSIDES
778AstrocytomaOFFSIDES
779AtaxiaOFFSIDES
780AtelectasisOFFSIDES
781AtherosclerosisOFFSIDES
782AthetosisOFFSIDES
783Atrial FlutterOFFSIDES
784Atrial tachycardiaOFFSIDES
785Avascular necrosisOFFSIDES
786B-cell lymphoma stage IIOFFSIDES
787Bacterial disease carrierOFFSIDES
788Bacterial sepsisOFFSIDES
789Band neutrophil percentage increasedOFFSIDES
790Basal cell carcinomaOFFSIDES
791Benign NeoplasmOFFSIDES
792Biliary adenomaOFFSIDES
793Biliary cirrhosisCanada Vigilance: 1Canada Vigilance
794Bilirubin conjugated increasedOFFSIDES
795BilirubinuriaOFFSIDES
796Biopsy bone abnormalOFFSIDES
797Biopsy breast abnormalOFFSIDES
798Biopsy breast normalOFFSIDES
799Biopsy gingivalOFFSIDES
800Biopsy lymph gland abnormalOFFSIDES
801Bladder calculus removalOFFSIDES
802Bladder cancer recurrentOFFSIDES
803Blood amylase decreasedOFFSIDES
804Blood calcium abnormalOFFSIDES
805Blood chloride increasedOFFSIDES
806Blood creatine phosphokinase decreasedOFFSIDES
807Blood electrolytes abnormalOFFSIDES
808Blood fibrinogenOFFSIDES
809Blood glucose decreasedOFFSIDES
810Blood insulinOFFSIDES
811Blood ketone bodyOFFSIDES
812Blood magnesium decreasedOFFSIDES
813Blood osmolarity decreasedOFFSIDES
814Blood pH decreasedOFFSIDES
815Blood parathyroid hormone increasedOFFSIDES
816Blood phosphorus decreasedOFFSIDES
817Blood uric acidOFFSIDES
818Bone density increasedOFFSIDES
819Bone fissureOFFSIDES
820Bone marrow depressionOFFSIDES
821BradyphreniaCanada Vigilance: 1Canada Vigilance
822Brain natriuretic peptide increasedOFFSIDES
823Breast necrosisOFFSIDES
824Breast prosthesis userOFFSIDES
825BronchiectasisOFFSIDES
826Bronchopleural FistulaOFFSIDES
827BursitisOFFSIDES
828CSF shunt removalOFFSIDES
829Cancer gene carrierOFFSIDES
830Carcinoembryonic antigen increasedOFFSIDES
831Cardiac asthmaOFFSIDES
832Cardiac procedure complicationOFFSIDES
833Cardiac stress test abnormalOFFSIDES
834Cardioactive drug level increasedOFFSIDES
835Carotid bruitOFFSIDES
836Cataract operationOFFSIDES
837Catheter related complicationOFFSIDES
838Cerebral ArteriosclerosisOFFSIDES
839Cerebral artery occlusionOFFSIDES
840Cerebral artery stenosisOFFSIDES
841Cerebral atrophyOFFSIDES
842Cerebral cystOFFSIDES
843CerebrosclerosisOFFSIDES
844Cervicobrachial syndromeOFFSIDES
845Chemical burn of skinOFFSIDES
846Chest wall painOFFSIDES
847CholangitisCanada Vigilance: 1Canada Vigilance
848Cholecystitis infectiveOFFSIDES
849CholesteatomaOFFSIDES
850Chronic Obstructive Airway DiseaseOFFSIDES
851Chronic sinusitisOFFSIDES
852ChylothoraxOFFSIDES
853ClumsinessOFFSIDES
854Colon cancer recurrentOFFSIDES
855Concomitant disease aggravatedOFFSIDES
856Congenital tricuspid valve incompetenceOFFSIDES
857Conjunctival depositOFFSIDES
858Contraindicated product prescribedCanada Vigilance: 1Canada Vigilance
859Corneal UlcerOFFSIDES
860Coronary artery insufficiencyOFFSIDES
861Cubital Tunnel SyndromeOFFSIDES
862Culture positiveOFFSIDES
863Culture wound positiveOFFSIDES
864Cutaneous CandidiasisOFFSIDES
865Cyst aspirationOFFSIDES
866Cyst removalOFFSIDES
867DebridementOFFSIDES
868Delusional disorder, unspecified typeOFFSIDES
869DemyelinationOFFSIDES
870Dental abscessOFFSIDES
871Dental alveolar anomalyOFFSIDES
872Dental cariesOFFSIDES
873Dental discomfortOFFSIDES
874Dental examinationOFFSIDES
875Denture wearerOFFSIDES
876Depressed Level of ConsciousnessOFFSIDES
877Device FailureOFFSIDES
878DiabetesOFFSIDES
879Diabetic RetinopathyOFFSIDES
880Diabetic foot infectionOFFSIDES
881DiverticulosisOFFSIDES
882DiverticulumOFFSIDES
883Drug ToleranceOFFSIDES
884Drug abuserOFFSIDES
885Drug addictOFFSIDES
886Drug toxicityOFFSIDES
887DuodenitisOFFSIDES
888DyscheziaOFFSIDES
889DysphasiaOFFSIDES
890Dyspnoea exacerbatedOFFSIDES
891Ejection Fraction DecreasedOFFSIDES
892Electrocardiogram ST-T segment abnormalOFFSIDES
893Electrocardiogram poor R-wave progressionOFFSIDES
894EmpyemaOFFSIDES
895Enterovesical FistulaOFFSIDES
896Epidural AbscessOFFSIDES
897Esophageal StenosisOFFSIDES
898Eustachian tube disorderOFFSIDES
899Eyelid infectionOFFSIDES
900Fatty LiverOFFSIDES
901Feeding tube complicationOFFSIDES
902Femoral arterial stenosisOFFSIDES
903Fibroadenoma of breastOFFSIDES
904FibroadenomaOFFSIDES
905Fibromuscular DysplasiaOFFSIDES
906Fistula repairOFFSIDES
907Fluid overloadOFFSIDES
908Foaming at mouthOFFSIDES
909Focal glomerulosclerosisOFFSIDES
910Freezing phenomenonOFFSIDES
911Fungal rashOFFSIDES
912Gallop rhythm presentOFFSIDES
913GamblingOFFSIDES
914GammopathyOFFSIDES
915Gastric infectionOFFSIDES
916Gastric mucosal lesionOFFSIDES
917GastroduodenitisOFFSIDES
918Gastrointestinal tract adenomaOFFSIDES
919General symptomOFFSIDES
920Germ Cell CancerOFFSIDES
921GlobulinuriaOFFSIDES
922GlossitisOFFSIDES
923GoiterOFFSIDES
924GonorrheaOFFSIDES
925GranulomaOFFSIDES
926Grip strengthOFFSIDES
927Hallucinations, mixedOFFSIDES
928Hay feverOFFSIDES
929Head BangingOFFSIDES
930HistoplasmosisOFFSIDES
931HoarsenessOFFSIDES
932HydronephrosisOFFSIDES
933HydropneumothoraxOFFSIDES
934HypercapniaOFFSIDES
935HyperpigmentationOFFSIDES
936HypervitaminosisOFFSIDES
937HypokinesiaOFFSIDES
938HypotensionCanada Vigilance: 1Canada Vigilance
939HypoxiaOFFSIDES
940HysteroscopyOFFSIDES
941Iliac artery occlusionOFFSIDES
942Iliac artery stenosisOFFSIDES
943Iliotibial Band SyndromeOFFSIDES
944ImmunosuppressionOFFSIDES
945Impaired self-careOFFSIDES
946Implant site inflammationOFFSIDES
947Implant site painOFFSIDES
948Implantable defibrillator insertionOFFSIDES
949Incision site infectionOFFSIDES
950Infected bunionOFFSIDES
951Influenza serology positiveOFFSIDES
952Infusion site irritationOFFSIDES
953Infusion site pruritusOFFSIDES
954Injection site burningOFFSIDES
955Injection site desquamationOFFSIDES
956Injection site stingingOFFSIDES
957Insulin ResistanceOFFSIDES
958Insulin-requiring type 2 diabetes mellitusOFFSIDES
959Intestinal hypomotilityOFFSIDES
960Intracranial HypotensionOFFSIDES
961Intracranial meningioma malignantOFFSIDES
962IridectomyOFFSIDES
963Jaw lesion excisionOFFSIDES
964Joint InstabilityOFFSIDES
965Joint sprainOFFSIDES
966Jugular vein distensionOFFSIDES
967Labile hypertensionOFFSIDES
968LacerationOFFSIDES
969Left Ventricular HypertrophyOFFSIDES
970Left atrial dilatationOFFSIDES
971Lesion excisionOFFSIDES
972LipaseOFFSIDES
973Low turnover osteopathyOFFSIDES
974Lumbar radiculopathyOFFSIDES
975Lymph node cancer metastaticOFFSIDES
976Lymphocyte percentage decreasedOFFSIDES
977MacrocytosisOFFSIDES
978MacrognathiaOFFSIDES
979Malignant HypertensionOFFSIDES
980Malignant melanoma in situOFFSIDES
981Malignant tumour excisionOFFSIDES
982Mammary duct ectasiaOFFSIDES
983MarasmusOFFSIDES
984Markedly reduced dietary intakeOFFSIDES
985Mastication disorderOFFSIDES
986MastoiditisOFFSIDES
987Maxillofacial operationOFFSIDES
988Mechanical ventilationOFFSIDES
989Medical device implantationOFFSIDES
990Medical device removalOFFSIDES
991Meningitis herpesOFFSIDES
992MetaplasiaOFFSIDES
993Metastases to abdominal cavityOFFSIDES
994Metastases to stomachOFFSIDES
995MetatarsalgiaOFFSIDES
996Micrographic skin surgeryOFFSIDES
997Mitral valve sclerosisOFFSIDES
998Monocyte percentage decreasedOFFSIDES
999MononeuritisOFFSIDES
1000Mood disorder due to a general medical conditionOFFSIDES
1001Multiple MyelomaOFFSIDES
1002Multiple sclerosis relapseOFFSIDES
1003Muscle flap operationOFFSIDES
1004Muscle necrosisOFFSIDES
1005Myasthenia GravisOFFSIDES
1006Myelodysplastic syndrome transformationOFFSIDES
1007MyringitisOFFSIDES
1008Neoplasm prophylaxisOFFSIDES
1009NephrectomyOFFSIDES
1010NeurectomyOFFSIDES
1011NeuromaOFFSIDES
1012Neuropathic ulcerOFFSIDES
1013Non-cardiac chest painOFFSIDES
1014Nuchal RigidityOFFSIDES
1015Nuclear magnetic resonance imaging abdominalOFFSIDES
1016NystagmusOFFSIDES
1017ObstructionOFFSIDES
1018Occult blood positiveOFFSIDES
1019OnycholysisOFFSIDES
1020Open reduction of fractureOFFSIDES
1021Optic AtrophyOFFSIDES
1022Optic Disc EdemaOFFSIDES
1023Optic NeuritisCanada Vigilance: 1Canada Vigilance
1024Oral Cavity FistulaOFFSIDES
1025OrthopneaOFFSIDES
1026OsteolysisOFFSIDES
1027OsteomaOFFSIDES
1028OsteosclerosisOFFSIDES
1029Pacemaker complicationOFFSIDES
1030Pain of skinOFFSIDES
1031Panic disorder with agoraphobiaOFFSIDES
1032PapillomaOFFSIDES
1033Parvovirus B19 serology positiveOFFSIDES
1034Pelvic fluid collectionOFFSIDES
1035Perianal erythemaOFFSIDES
1036Peripheral paralysisOFFSIDES
1037Physical breast examination abnormalOFFSIDES
1038PingueculaOFFSIDES
1039PlasmacytosisOFFSIDES
1040PleurisyOFFSIDES
1041PneumothoraxOFFSIDES
1042PolyuriaOFFSIDES
1043Poor dental conditionOFFSIDES
1044Post procedural painOFFSIDES
1045Post procedural pulmonary embolismOFFSIDES
1046Posterior CapsulotomyOFFSIDES
1047Postoperative adhesionOFFSIDES
1048Postoperative infectionOFFSIDES
1049Postoperative wound complicationOFFSIDES
1050PresbyopiaOFFSIDES
1051Primary sequestrumOFFSIDES
1052Procedural hypertensionOFFSIDES
1053ProctitisOFFSIDES
1054Progesterone receptor assay negativeOFFSIDES
1055Progesterone receptor assayOFFSIDES
1056Pruritus allergicOFFSIDES
1057PseudocystOFFSIDES
1058Psychiatric symptomOFFSIDES
1059Pulmonary radiation injuryOFFSIDES
1060PurulenceOFFSIDES
1061Radicular CystOFFSIDES
1062RalesOFFSIDES
1063Rebound hypertensionOFFSIDES
1064Rectal polypOFFSIDES
1065Reflux gastritisOFFSIDES
1066Reflux laryngitisOFFSIDES
1067Regurgitation of foodOFFSIDES
1068Renal cystOFFSIDES
1069Respiratory tract congestionOFFSIDES
1070Retinal Vein OcclusionOFFSIDES
1071Retinal vascular occlusionOFFSIDES
1072RhinalgiaOFFSIDES
1073Rhinitis perennialOFFSIDES
1074RhinorrheaOFFSIDES
1075Ruptured cerebral aneurysmOFFSIDES
1076SacroiliitisOFFSIDES
1077ScotomaOFFSIDES
1078Secondary sequestrumOFFSIDES
1079Serum SicknessOFFSIDES
1080Shoulder PainOFFSIDES
1081Shunt infectionOFFSIDES
1082Silent myocardial infarctionOFFSIDES
1083Sinus antrostomyOFFSIDES
1084Sinus operationOFFSIDES
1085Sinus polypOFFSIDES
1086Skin discomfortOFFSIDES
1087Skin lacerationOFFSIDES
1088Skin neoplasm excisionOFFSIDES
1089SmokerOFFSIDES
1090Soft tissue necrosisOFFSIDES
1091Spinal claudicationOFFSIDES
1092Spinal fusion surgeryOFFSIDES
1093SplenectomyOFFSIDES
1094SplinterOFFSIDES
1095SpondylolisthesisOFFSIDES
1096SpondylosisOFFSIDES
1097Sputum culture positiveOFFSIDES
1098Sternal injuryOFFSIDES
1099Suture related complicationOFFSIDES
1100T-Cell LymphomaOFFSIDES
1101Tardive DyskinesiaOFFSIDES
1102Tarsal Tunnel SyndromeOFFSIDES
1103TenosynovitisOFFSIDES
1104Therapeutic procedureOFFSIDES
1105Therapeutic product effect decreasedCanada Vigilance: 6Canada Vigilance
1106Therapeutic product effect delayedCanada Vigilance: 1Canada Vigilance
1107Thoracic vertebral fractureOFFSIDES
1108ThrombophlebitisCanada Vigilance: 2Canada Vigilance
1109Tooth ExtractionOFFSIDES
1110Tooth InfectionOFFSIDES
1111Tooth repairOFFSIDES
1112TracheitisOFFSIDES
1113Transfusion ReactionOFFSIDES
1114Tri-iodothyronine uptake decreasedOFFSIDES
1115Troponin increasedOFFSIDES
1116Ultrasound biliary tractOFFSIDES
1117Ultrasound breast abnormalOFFSIDES
1118Ultrasound thyroid abnormalOFFSIDES
1119Ultrasound uterus abnormalOFFSIDES
1120Umbilical herniaOFFSIDES
1121Unexpected therapeutic drug effectOFFSIDES
1122Urethral strictureOFFSIDES
1123Urge IncontinenceCanada Vigilance: 1Canada Vigilance
OFFSIDES
1124Urinary tract infection pseudomonalOFFSIDES
1125Uterovaginal prolapseOFFSIDES
1126Ventricular FibrillationOFFSIDES
1127Ventricular hypokinesiaOFFSIDES
1128Vertebral Artery StenosisOFFSIDES
1129VitrectomyOFFSIDES
1130Walking aid userOFFSIDES
1131Wheelchair userOFFSIDES
1132Withdrawal of life supportOFFSIDES
1133Wound closureOFFSIDES
1134Wound infection bacterialOFFSIDES
1135Wound necrosisOFFSIDES
1136Wrist deformityOFFSIDES
1137colonoscopyOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.